Clinical Professor/Senior Lecturer & Honorary Consultant in Medical Oncology (Research and Teaching) (Hepato-pancreatico-billiary (HPB) and Neuroendocrine Neoplasms (NENs))
The Christie NHS Foundation Trust, Withington, Manchester
1.0 FTE 10 programmed activities (5 clinical and 5 academic)
Applications are invited for a full-time Clinical Senior Lecturer or Professor in the Division of Cancer Sciences in the Hepato-pancreatico-biliary (HPB) and neuroendocrine neoplasm (NENs) disease group.
The appointee will be based at The Christie NHS Foundation Trust and will provide consultant level care for patients with Hepato-pancreatico-biliary (HPB) and Neuroendocrine neoplasms (NENs).
There are three consultants currently working in the HPB (composed of primary liver cancer (hepatocellular carcinoma), pancreas cancer, biliary tract cancers (cholangiocarcinoma and gallbladder cancer) and NEN disease group; Professor Juan Valle, Dr Richard Hubner, and Dr Mairéad McNamara. Two further consultant posts (1 x 1.0 and 1 x 0.5 Whole Time Equivalents (WTEs)), additional to this post, for the HPB/NET disease group are due to be advertised. The successful applicant will replace Professor Valle in this consultant body covering patients with these primaries. The group has a very active clinical research programme (predominantly phase II/III), with close links to basic research laboratories in the Cancer Research United Kingdom (UK) Manchester Institute. Approximately 500 new patients are seen each year (80% with advanced/metastatic disease), and approximately 23% of all these patients are entered into clinical trials. In addition, The Christie has an international reputation in the treatment of NENs (accredited as a Centre of Excellence by the European NET Society (ENETS), initially in 2011).
Trial activity is embedded within clinical service activity across all disease groups at The Christie and the post holder will be expected to maintain existing research and trial activity within the disease group, working with colleagues from Research and Innovation.
You will also be supported in the development of an independent and aspirational research programme within the Division of Cancer Sciences. Your programme will complement the Division’s multidisciplinary portfolio of research. Working collaboratively, you will continue to drive world-leading research in the HPB and NENs subject area and further enhance the institution’s strengths in this area. You will contribute to undergraduate and postgraduate teaching programmes within the School of Medical Sciences and the wider University, with opportunities to develop curriculum, innovative teaching and provide an exceptional student experience through research-led learning, as appropriate.
At Manchester, we embrace, celebrate and respect difference. We support each other to create an environment where everyone is able to reach their full potential. The Division’s ethos is to promote an inclusive and representative environment where all staff and students have voices with potential to influence positive change. We encourage applications from talented individuals from wide and diverse backgrounds, and in particular those currently underrepresented. The School of Medical Sciences holds a Silver Athena SWAN award which recognises good practice in relation to gender, flexible working arrangements, family-friendly policies, and good work-life balance. All appointments are made on merit.
The Manchester Cancer Research Centre: https://www.mcrc.manchester.ac.uk/
Informal and subject/theme-specific enquiries: Stephen Taylor - Leech Professor of Pharmacology and Head of the Division of Cancer Sciences. Email: firstname.lastname@example.org
Dr Yvonne Summers Clinical Director of Medical Oncology Yvonne.Summers@nhs.net
Informal inquiries may also be made to Professor Juan Valle (email@example.com) or Dr Mairéad McNamara (firstname.lastname@example.org)
Recruiting manager: Natalia Rossi – Operations Manager for the Division of Cancer Sciences. Email: email@example.com
BMH-022000 Clinical Professor Senior Lecturer & Honorary Consultant in Medical Oncology (Research and Teaching) (Hepato-pancreatico-billiary (HPB) and Neuroendocrine Neoplasms (NENs)) FPs
Closing date: 7 July 2023.